Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 11, 2002

Primary Completion Date

July 31, 2006

Study Completion Date

June 30, 2007

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

dalteparin

RADIATION

radiation therapy

Trial Locations (12)

49007

West Michigan Cancer Center, Kalamazoo

55416

CCOP - Metro-Minnesota, Saint Louis Park

55905

Mayo Clinic Cancer Center, Rochester

61801

CCOP - Carle Cancer Center, Urbana

74136

CCOP - Oklahoma, Tulsa

76508

CCOP - Scott and White Hospital, Temple

33612-9497

H. Lee Moffitt Cancer Center and Research Institute, Tampa

49007-3731

CCOP - Kalamazoo, Kalamazoo

03756-0002

Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon

37232-6307

Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center, Nashville

54307-3453

CCOP - St. Vincent Hospital Cancer Center, Green Bay, Green Bay

53792-0001

University of Wisconsin Comprehensive Cancer Center, Madison

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00028678 - Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme | Biotech Hunter | Biotech Hunter